Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Narrow
4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】
Earnings ReportD.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on February 10th (15:30). The consolidated net loss for the fiscal year ending December 2024 expanded to a loss of 1.29 billion yen (compared to a loss of 0.81 billion yen in the previous period), but it is expected to shrink to loss of 0.68 billion yen for the fiscal year ending December 2025. This will mark the sixth consecutive term of losses.
In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 0.56 billion yen (compared to a loss of 0.36 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -296.5% in the same period last year to -456.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 448 | -305 | -295 | -429 | -14.5 | 0 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 428 | -798 | -796 | -812 | -25.6 | 0 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 471 | -1,209 | -1,228 | -1,290 | -36.7 | 0 | Feb 10, 2025 | J-GAAP |
YoY | +10.0% | -51.5% | -54.3% | -58.9% | -43.7% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 471 | -1,209 | -1,228 | -1,290 | -31.0 | 0 | Jan 16, 2025 | J-GAAP |
Dec, 2024 Results | 471 | -1,209 | -1,228 | -1,290 | -36.7 | 0 | Feb 10, 2025 | J-GAAP |
Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | -18.6% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 223 | -449 | -459 | -520 | -16.2 | 0 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 10, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 428 | -798 | -796 | -812 | -25.6 | 0 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 471 | -1,209 | -1,228 | -1,290 | -36.7 | 0 | Feb 10, 2025 | J-GAAP |
Dec, 2025 Guidance | 400 | -670 | -680 | -680 | -14.9 | 0 | Feb 10, 2025 | J-GAAP |
YoY | -15.1% | +44.6% | +44.6% | +47.3% | +59.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 115 | -341 | -343 | -369 | -11.6 | -296.5 | Feb 9, 2024 | J-GAAP |
Jan - Mar, 2024 | 104 | -318 | -320 | -320 | -10.0 | -305.8 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 119 | -131 | -139 | -200 | -6.2 | -110.1 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 125 | -198 | -206 | -207 | -6.2 | -158.4 | Nov 14, 2024 | J-GAAP |
Oct - Dec, 2024 | 123 | -562 | -563 | -563 | -16.0 | -456.9 | Feb 10, 2025 | J-GAAP |
YoY | +7.0% | -64.8% | -64.1% | -52.6% | -38.0% |
Related Articles
SAITA, Oct-Dec (2Q) Ordinary Profit Increases by 2.7 times
YUKEN KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 28%, Oct-Dec Ordinary Profit Increases by 17%
COMO, Oct-Dec (3Q) Ordinary Profit Decreases by 92%
Keio, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%
MATSUYA FOODS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 4%, Exceeds Full-Year Plan
ASAHI RUBBER, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 48%
EBARA JITSUGYO, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 25 yen
Medical Data Vision, Returning to Profitability This Year, Dividend Raised by 2.5 yen
TAKI CHEMICAL, 41% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 5 yen
NOHMI BOSAI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.1 times, Oct-Dec Ordinary Profit Increases by 2.0 times